| |
|
|
|
ImmunoGen Inc.  
|
|
1.99 0.06 (0.03%) |
05-24 16:00 |
|
Open: |
1.93 |
Pre close: |
1.93 |
Target:
|
3.32
|
|
High: |
1.99 |
Low: |
1.88 |
Resistance:
|
2.84
3.47
|
|
Volume: |
3,730,026 |
Market Cap: |
298M |
Support:
|
1.83
1.52
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.95
 |
MACD |
MACD(12,26):
|
-0.23 |
|
MA(20): |
2.55 |
Signal(12,26,9): |
-0.14 |
|
MA(100): |
3.65 |
Stochastic Oscillator |
%K(14,3):
|
5.92  |
|
MA(250): |
6.44 |
%D(3): |
4.07 |
|
Average Volume(K) |
3-Month: |
415254
|
52-Week |
High:
|
12.31 |
|
10-Days: |
587792 |
Low: |
1.83 |
|
RSI |
RSI(14):
|
35.40 |
Change(%): |
-80.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.190 |
Return on Equity (ttm) |
573.5 |
Shares Out. (M) |
149.53 |
|
EPS Est. Current Year |
-0.720 |
Return on Assets (ttm) |
-61.6 |
Shares Float (M) |
147.25 |
|
EPS Est. Next Year |
-1.380 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
-56.7 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.950 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
39.250 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.67 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.05 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-106.26 |
P/S |
1026085184.00 |
|
Operating Margin |
-388.09 |
Levered Free Cash Flow
(M) |
-89.36 |
P/CF |
-2.80 |
|
|
|
|
|
|
